Baolingbao Biology Co Ltd - SERIES A

SZSE:002286 (China)   (0 % min) Medium Term Notes 2005-15.3.17 Sr Series A Fltg Rt
Â¥ 5.88 (-2.97%) Jun 5
36.75
P/B:
1.11
Market Cap:
Â¥ 2.17B ($ 300.67M)
Enterprise V:
Â¥ 2.34B ($ 323.98M)
Volume:
4.24M
Avg Vol (2M):
8.75M
Volume:
4.24M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Baolingbao Biology Co Ltd ( ) from 2009 to Jun 05 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Baolingbao Biology stock (SZSE:002286) PE ratio as of Jun 05 2024 is 36.75. More Details

Baolingbao Biology Co Ltd (SZSE:002286) PE Ratio (TTM) Chart

To

Baolingbao Biology Co Ltd (SZSE:002286) PE Ratio (TTM) Historical Data

Total 1198
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Baolingbao Biology PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-05 36.8 2024-03-27 41.0
2024-06-04 37.9 2024-03-26 42.3
2024-06-03 38.8 2024-03-25 40.2
2024-05-31 39.5 2024-03-22 41.4
2024-05-30 39.9 2024-03-21 42.2
2024-05-29 40.5 2024-03-20 41.8
2024-05-28 40.6 2024-03-19 41.2
2024-05-27 41.5 2024-03-18 40.9
2024-05-24 41.3 2024-03-15 40.3
2024-05-23 40.4 2024-03-14 39.7
2024-05-22 41.4 2024-03-13 40.0
2024-05-21 41.8 2024-03-12 40.0
2024-05-20 41.9 2024-03-11 39.7
2024-05-17 41.7 2024-03-08 38.3
2024-05-16 41.8 2024-03-07 38.8
2024-05-15 41.5 2024-03-06 38.6
2024-05-14 41.8 2024-03-05 38.1
2024-05-13 42.4 2024-03-04 39.3
2024-05-10 43.2 2024-03-01 39.7
2024-05-09 42.8 2024-02-29 39.7
2024-05-08 43.6 2024-02-28 38.5
2024-05-07 43.3 2024-02-27 41.3
2024-05-06 41.6 2024-02-26 40.5
2024-04-30 39.3 2024-02-23 39.7
2024-04-29 37.9 2024-02-22 38.5
2024-04-26 36.3 2024-02-21 37.5
2024-04-25 36.5 2024-02-20 36.7
2024-04-24 35.9 2024-02-19 36.1
2024-04-23 34.9 2024-02-08 34.9
2024-04-22 34.0 2024-02-07 32.2
2024-04-19 34.1 2024-02-06 35.6
2024-04-18 34.3 2024-02-05 37.3
2024-04-17 34.9 2024-02-02 41.4
2024-04-16 32.2 2024-02-01 42.8
2024-04-15 35.6 2024-01-31 44.7
2024-04-12 38.1 2024-01-30 47.1
2024-04-11 38.6 2024-01-29 49.0
2024-04-10 38.6 2024-01-26 50.6
2024-04-09 39.9 2024-01-25 50.0
2024-04-08 39.1 2024-01-24 47.4
2024-04-03 39.9 2024-01-23 46.6
2024-04-02 39.4 2024-01-22 47.6
2024-04-01 39.4 2024-01-19 51.1
2024-03-29 38.4 2024-01-18 51.6
2024-03-28 38.3 2024-01-17 53.1

Baolingbao Biology Co Ltd (SZSE:002286) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Baolingbao Biology Co Ltd
NAICS : 325411 SIC : 2833
ISIN : CNE100000FL1

Share Class Description:

SZSE:002286: (0 % min) Medium Term Notes 2005-15.3.17 Sr Series A Fltg Rt
Description
Baolingbao Biology Co Ltd is engaged in providing biotechnology products and services. The products of the company include oligosaccharide, carbohydrate, sugar alcohol, dietary fiber, starch series, and syrup series.